AMP95s

AMP95s refers to a specific class of selective androgen receptor modulators, often abbreviated as SARMs. These compounds are designed to bind to androgen receptors in the body, mimicking the effects of androgens like testosterone. However, their intended mechanism is to do so with greater selectivity for certain tissues, such as muscle and bone, while minimizing the androgenic side effects often associated with traditional anabolic steroids.

The development of AMP95s, like other SARMs, was initially driven by research into potential therapeutic applications. These include treating conditions characterized by muscle wasting, such as sarcopenia, cachexia, and osteoporosis. The goal was to provide a way to promote muscle and bone growth without the widespread systemic effects and potential health risks associated with anabolic steroids.

However, AMP95s are not approved for human consumption by regulatory bodies like the FDA. Their sale and distribution are often found in a grey market, marketed as research chemicals. This means that their purity, dosage, and long-term safety have not been rigorously established through clinical trials. Athletes and bodybuilders may use them to enhance performance, but this is done at their own risk due to the lack of regulatory oversight and potential for unknown side effects. The legal status and availability of these compounds can vary by region.